Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Cited by (1,000)

Items 301–400 of 1,000

1. Epidemiology and Clinical Presentation of COVID-19 in Older Adults
   Yasin Abul, Ciera Leeder, Stefan Gravenstein · 2022 · Clinics in Geriatric Medicine
2. Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients
   Sergej Tomić, Jelena Đokić, Dejan Stevanović, Nataša Ilić, Alisa Gruden‐Movsesijan, Miroslav Dinić, Dušan Radojević, Marina Bekić, Nebojša Mitrović, Ratko Tomašević et al. · 2021 · Frontiers in Immunology
3. Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches
   Amal Hasan, Ebaa Al‐Ozairi, Zahraa Albaqsumi, Rasheed Ahmad, Fahd Al‐Mulla · 2021 · ImmunoTargets and Therapy
4. Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19
   José Felipe Varona, Pedro Landete, Jose Antonio Lopez-Martin, Vicente Estrada, Roger Paredes, Pablo Guisado‐Vasco, Lucía Fernández de Orueta, Miguel Torralba, Jesús Fortün, Roberto Vates et al. · 2022 · Life Science Alliance
5. The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime
   Marco Chilosi, Venerino E. Poletti, Claudia Ravaglia, Giulio Rossi, Alessandra Dubini, Sara Piciucchi, Federica Pedica, Vincenzo Bronte, Giovanni Pizzolo, Guido Martignoni et al. · 2021 · Modern Pathology
6. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73- Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes
   Parimah Ahmadi, Philip Hartjen, Matin Kohsar, Silke Kummer, Stefan Schmiedel, Jan‐Hendrik Bockmann, Anahita Fathi, Samuel Huber, Friedrich Haag, Julian Schulze zur Wiesch · 2020 · Cells
7. Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID‐19 in type 2 diabetes
   Fawaz Alzaïd, Jean‐Baptiste Julla, Marc Diedisheim, Charline Potier, Louis Potier, Gilberto Velho, Bénédicte Gaborit, Philippe Manivet, Stéphane Germain, Tiphaine Vidal-Trécan et al. · 2020 · EMBO Molecular Medicine
8. A streamlined whole blood CyTOF workflow defines a circulating immune cell signature of COVID ‐19
   Daniel Geanon, Brian Hyohyoung Lee, Edgar Gonzalez‐Kozlova, Geoffrey Kelly, Diana Handler, Bhaskar Upadhyaya, John M. Leech, Ronaldo Miguel de Real, Manon Herbinet, Assaf Magen et al. · 2021 · Cytometry Part A
9. Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
   Corrado Pelaia, Cecilia Calabrese, Eugenio Garofalo, Andrea Bruni, Alessandro Vatrella, Girolamo Pelaia · 2021 · International Journal of Molecular Sciences
10. The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses
    Delia Goletti, Linda Petrone, Davide Manissero, Antonio Bertoletti, Sonia N. Rao, Nduku Ndunda, Alessandro Sette, Vladyslav Nikolayevskyy · 2021 · Clinical Microbiology and Infection
11. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
    Asim Azhar, Wajihul Hasan Khan, Parvez Anwar Khan, Khaled A. Alhosaini, Mohammad Owais, Aijaz Ahmad · 2022 · Journal of Infection and Public Health
12. Immune responses in mildly versus critically ill COVID-19 patients
    Hamid Nasrollahi, Atefe Ghamar Talepoor, Zahra Saleh, Mahsa Eshkevar Vakili, Paria Heydarinezhad, Narges Karami, Maryam Noroozi, Seppo Meri, Kurosh Kalantar · 2023 · Frontiers in Immunology
13. More bricks in the wall against SARS-CoV-2 infection: involvement of γ9δ2 T cells
    Ger T. Rijkers, Trees Vervenne, Pieter van der Pol · 2020 · Cellular and Molecular Immunology
14. Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients
    Qihong Yan, Pingchao Li, Xianmiao Ye, Xiaohan Huang, 莫晓能, Qian Wang, Yudi ZHANG, Luo Kun, Zhaoming Chen, Jia Luo et al. · 2021 · The Journal of Immunology
15. Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action
    Somayeh Sadeghi, Sara Soudi, Abbas Shafiee, Seyed Mahmoud Hashemi · 2020 · Life Sciences
16. Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
    Caroline Ruetsch-Chelli, Vesna Brglez, Marion Crémoni, Kévin Zorzi, Céline Fernandez, Sonia Boyer‐Suavet, Sylvia Benzaken, Élisa Demonchy, Karine Risso, Johan Courjon et al. · 2021 · Frontiers in Medicine
17. T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19
    Olatz Zenarruzabeitia, Gabirel Astarloa-Pando, Iñigo Terrén, Ane Orrantia, Raquel Pérez-Garay, Iratxe Seijas, Javier Nieto Arana, Natale Imaz-Ayo, Sílvia Pérez-Fernández, Eunate Arana‐Arri et al. · 2021 · Frontiers in Immunology
18. The association between vitamin D levels and the clinical severity and inflammation markers in pediatric COVID-19 patients: single-center experience from a pandemic hospital
    Elvan Bayramoğlu, Gülşen Akkoç, Ayşe Ağbaş, Özlem Akgün, Kamer Yurdakul, Nilgün Selçuk Duru, Murat Elevli · 2021 · European Journal of Pediatrics
19. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients
    Muhammad Umair Mushtaq, Moazzam Shahzad, Sibgha Gull Chaudhary, Mary Luder, Nausheen Ahmed, Haitham Abdelhakim, Rajat Bansal, Ramesh Balusu, Shaun DeJarnette, Clint L. Divine et al. · 2021 · Transplantation and Cellular Therapy
20. Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice
    Mehran Ghasemzadeh, Alireza Ghasemzadeh, Ehteramolsadat Hosseini · 2021 · Human Immunology
21. COVID-19 in the Cancer Patient
    Cindy B. Yeoh, Kathleen J. Lee, Elizabeth F. Rieth, Renee Mapes, Anna V. Tchoudovskaia, Gregory W. Fischer, Luis Etienne Tollinche · 2020 · Anesthesia & Analgesia
22. COVID‐19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS‐CoV‐2
    Annalisa Mondi, Eleonora Cimini, Francesca Colavita, Stefania Cicalini, Carmela Pinnetti, Giulia Matusali, Rita Casetti, Markus J. Maeurer, Alessandra Vergori, Valentina Mazzotta et al. · 2020 · Journal of Medical Virology
23. Maternal natural killer cells at the intersection between reproduction and mucosal immunity
    Evgeniya V. Shmeleva, Francesco Colucci · 2021 · Mucosal Immunology
24. Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators
    Daniela Ricci, Marilena Paola Etna, Fabiana Rizzo, Silvia Sandini, Martina Severa, Eliana Marina Coccia · 2021 · International Journal of Molecular Sciences
25. NK cell dysfunction in patients with COVID-19
    Jiacheng Bi · 2022 · Cellular and Molecular Immunology
26. Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial
    Cármen Lúcia Kuniyoshi Rebelatto, Alexandra Cristina Senegaglia, Cláudio Luciano Franck, Débora Regina Daga, Patrícia Shigunov, Marco Augusto Stimamiglio, Daniela Boscaro Marsaro, Bruna Schaidt, Andressa Micosky, Ana Paula de Azambuja et al. · 2022 · Stem Cell Research & Therapy
27. The Effects of Tai Chi and Qigong on Immune Responses: A Systematic Review and Meta-Analysis
    B. Oh, Kyeore Bae, G. Lamoury, T. Eade, F. Boyle, Brian P. Corless, S. Clarke, A. Yeung, D. Rosenthal, L. Schapira et al. · 2020 · Medicines
28. Gamma Delta T Cells and Their Involvement in COVID-19 Virus Infections
    Georg von Massow, Steve K. W. Oh, Alan Tin‐Lun Lam, Kenth T. Gustafsson · 2021 · Frontiers in Immunology
29. Programmed cell death: the pathways to severe COVID-19?
    Stefanie M. Bader, James P. Cooney, Marc Pellegrini, Marcel Doerflinger · 2022 · Biochemical Journal
30. Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19
    Ting Lu, Rui Ma, Wen-Juan Dong, Kun-Yu Teng, Daniel S. Kollath, Zhi-Yao Li, Jinhee Yi, C. Bustillos, Shou-Bao Ma, L. Tian et al. · 2022 · Nature Communications
31. Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection
    Narjes Saheb Sharif‐Askari, Fatemeh Saheb Sharif‐Askari, Bushra Mdkhana, Saba Al Heialy, Habiba S. AlSafar, Rifat Hamoudi, Qutayba A. Hamid, Rabih Halwani · 2020 · Molecular Therapy — Methods & Clinical Development
32. How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19
    Ludmila Müller, Svetlana Di Benedetto · 2021 · International Journal of Molecular Sciences
33. Immune Immunomodulation in Coronavirus Disease 2019 (COVID-19): Strategic Considerations for Personalized Therapeutic Intervention
    Mark W. Hall, Ila Joshi, Luis O. Leal, Eng Eong Ooi · 2020 · Clinical Infectious Diseases
34. Association between markers of immune response at hospital admission and COVID‐19 disease severity and mortality: A meta‐analysis and meta‐regression
    Jaskaran Khinda, Naveed Zafar Janjua, Shannon S.Y. Cheng, Edwin R. van den Heuvel, Parveen Bhatti, Maryam Darvishian · 2020 · Journal of Medical Virology
35. A Model for SARS-CoV-2 Infection with Treatment
    Amar Nath Chatterjee, Fahad Al Basir · 2020 · Computational and Mathematical Methods in Medicine
36. Role of T cells in severe COVID-19 disease, protection, and long term immunity
    Julia Maret Hermens, Can Keşmir · 2023 · Immunogenetics
37. IL-15 immunotherapy is a viable strategy for COVID-19
    Hemanth Kumar Kandikattu, Sathisha Upparahalli Venkateshaiah, Sandeep Kumar, Anil Mishra · 2020 · Cytokine & Growth Factor Reviews
38. Novel therapeutic approaches for treatment of COVID-19
    Nikoo Hossein‐Khannazer, Bahare Shokoohian, Anastasia I. Shpichka, Hamid Asadzadeh Aghdaei, Peter S. Timashev, Massoud Vosough · 2020 · Journal of Molecular Medicine
39. Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection
    Rosaria Talarico, Chiara Stagnaro, Francesco Ferro, Linda Carli, Marta Mosca · 2020 · The Lancet Rheumatology
40. The Metabolic Changes and Immune Profiles in Patients With COVID-19
    Bing He, Jun Wang, Yudie Wang, Juan Zhao, Juan Huang, Yu Tian, Cheng‐Ta Yang, Heng Zhang, Mingxia Zhang, Lixing Gu et al. · 2020 · Frontiers in Immunology
41. Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?
    Jon Hazeldine, Janet M. Lord · 2020 · Frontiers in Immunology
42. Pathogenesis‐directed therapy of 2019 novel coronavirus disease
    Charles W. Stratton, Yi‐Wei Tang, Hongzhou Lu · 2020 · Journal of Medical Virology
43. Hyperinflammation and Immune Response Generation in COVID-19
    K.P. Mishra, Ajay Kumar Singh, Shashi Bala Singh · 2020 · NeuroImmunoModulation
44. COVID-19-associated liver injury: from bedside to bench
    Dongxiao Li, Xiangming Ding, Meng Xie, Dean Tian, Limin Xia · 2021 · Journal of Gastroenterology
45. Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019
    Mohamed Fizur Nagoor Meeran, Hayate Javed, Charu Sharma, Sameer N. Goyal, Sanjay Kumar, Niraj Kumar Jha, Shreesh Kumar Ojha · 2021 · Heliyon
46. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
    Rebar N. Mohammed, Rozita Tamjidifar, Heshu Sulaiman Rahman, Ali Adili, Shadi Ghoreishizadeh, Hossein Saeedi, Lakshmi Prasanth Thangavelu, Navid Shomali, Ramin Aslaminabad, Faroogh Marofi et al. · 2022 · Cell Communication and Signaling
47. Long COVID-19 Pathophysiology: What Do We Know So Far?
    Nikolaos Tziolos, Πέτρος Ιωάννου, Stella Baliou, Diamantis P. Kofteridis · 2023 · Microorganisms
48. Major reduction of NKT cells in patients with severe COVID-19 pneumonia
    Maria Antonella Zingaropoli, Valentina Perri, Patrizia Pasculli, Francesco Cogliati Dezza, Parni Nijhawan, Giulia Savelloni, Giuseppe La Torre, Claudia D’Agostino, Fabio Mengoni, Miriam Lichtner et al. · 2020 · Clinical Immunology
49. Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19
    Sara Lega, Samuele Naviglio, Stefano Volpi, Alberto Tommasini · 2020 · Vaccines
50. Insight into the pediatric and adult dichotomy of COVID‐19: Age‐related differences in the immune response to SARS‐CoV‐2 infection
    Allison Fialkowski, Yaël Gernez, Puneeta Arya, Katja Gabriele Weinacht, Thomas Bernard Kinane, Lael M. Yonker · 2020 · Pediatric Pulmonology
51. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)
    Seyed Mohammad Reza Hashemian, Navid Shafigh, Golnaz Sadat Afzal, Hamidreza Jamaati, Payam Tabarsi, Majid Marjani, Majid Malekmohammad, Seyed Mehdi Mortazavi, Batoul Khoundabi, Davood Mansouri et al. · 2020 · Pulmonology
52. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway
    Marion Anliker‐Ort, Jasper Dingemanse, John van den Anker, Priska Kaufmann · 2020 · Frontiers in Immunology
53. PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses
    Hee Ho Park, Hyelim Kim, Han Sol Lee, Eun U Seo, Ji-Eun Kim, Jee-Hyun Lee, Yong‐Hyeon Mun, So-Yeol Yoo, Jiseon An, Mi‐Young Yun et al. · 2021 · Biomaterials
54. Vitamin D3 as Potential Treatment Adjuncts for COVID-19
    Lucia Malaguarnera · 2020 · Nutrients
55. Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans
    Rajneesh Srivastava, Swapna Vidhur Daulatabad, Mansi Srivastava, Sarath Chandra Janga · 2020 · International Journal of Molecular Sciences
56. Dysregulation of the immune response in coronavirus disease 2019
    Leila Mohamed Khosroshahi, Nima Rezaei · 2020 · Cell Biology International
57. Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020)
    David S. Kim, S. Rowland-Jones, E. Gea-Mallorquí · 2020 · Frontiers in Immunology
58. Dynamic Changes of Lymphocyte Subsets in the Course of COVID-19
    Mitra Sadat Rezaei, Majid Marjani, Shima Mahmoudi, Esmaeil Mortaz, Davood Mansouri · 2021 · International Archives of Allergy and Immunology
59. Lymphopenia in Covid-19: A single center retrospective study of 589 cases
    El Aidouni Ghizlane, Manal Merbouh, El Kaouini Abderrahim, Abdelilah El Rhalete, Mohammed Maarad, Rajae Alkouh, Mohammed Amine Bouazzaoui, Houssam Bkiyar, Naïma Abda, Housni Brahim · 2021 · Annals of Medicine and Surgery
60. Why Severe COVID-19 Patients Are at Greater Risk of Developing Depression: A Molecular Perspective
    Ana Paula Bouças, Jakeline Rheinheimer, Jim Lagopoulos · 2020 · The Neuroscientist
61. Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation
    Marco Cardone, Masahide Yano, Amy S. Rosenberg, Montserrat Puig · 2020 · Frontiers in Immunology
62. Nexus between COVID-19 and periodontal disease
    Kanchana Sukumar, Anupama Tadepalli · 2021 · Journal of International Medical Research
63. Clinical Significance of Micronutrient Supplementation in Critically Ill COVID-19 Patients with Severe ARDS
    Quirin Notz, J. Herrmann, T. Schlesinger, P. Helmer, S. Sudowe, Qian Sun, J. Hackler, D. Roeder, C. Lotz, P. Meybohm et al. · 2021 · Nutrients
64. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection
    Roberto Littera, Luchino Chessa, Silvia Deidda, Goffredo Angioni, Marcello Campagna, Sara Lai, Maurizio Melis, Selene Cipri, Davide Firinu, Simonetta Santus et al. · 2021 · PLoS ONE
65. Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment
    Norma A. Valdez-Cruz, E. García-Hernández, C. Espitia, L. Cobos-Marín, C. Altamirano, Carlos G. Bando-Campos, L. F. Cofas-Vargas, E. W. Coronado-Aceves, Ricardo A. González-Hernández, Pablo Hernández-Peralta et al. · 2021 · Microbial Cell Factories
66. Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity
    Federica Maria Bozzano, Chiara Dentone, Carola Perrone, Antonio Di Biagio, Daniela Fenoglio, Alessia Parodi, Małgorzata Mikulska, Bianca Marisa Bruzzone, Daniele Roberto Giacobbe, Antonio Vena et al. · 2021 · PLoS Pathogens
67. AI-guided discovery of the invariant host response to viral pandemics
    Debashis Sahoo, Gajanan Dattatray Katkar, Soni Khandelwal, Mahdi Behroozikhah, Amanraj Claire, Vanessa Castillo, Courtney Tindle, Mackenzie Fuller, Sahar Taheri, Thomas F. Rogers et al. · 2021 · EBioMedicine
68. Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview
    Anamika Gupta, Hezlin Marzook, Firdos Ahmad · 2022 · Clinical and Experimental Medicine
69. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
    Esther Moga, Elionor Lynton‐Pons, Peré Domingo · 2022 · Frontiers in Immunology
70. Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19
    Kholoud F. Aliter, Rami A. Al‐Horani · 2020 · Cardiovascular Drugs and Therapy
71. An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis
    Yili Liu, Daihong Chen, Junjie Hou, Haicong Li, Dan Cao, Mingquan Guo, Yun Ling, Menglu Gao, Yi Zhou, Yanmin Wan et al. · 2020 · Cytokine
72. Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer
    Remy J.H. Martens, Arjan J. van Adrichem, Nadine J.A. Mattheij, Calvin G. Brouwer, Daan J.L. van Twist, Jasper J. C. R. Broerse, César Magro Checa, Christel M. P. van Dongen, Rémy L.M. Mostard, Sofía Ramiro et al. · 2020 · Clinical Chemistry and Laboratory Medicine (CCLM)
73. The role of NK cells in fighting the virus infection and sepsis
    Lu Ma, Qi Li, Suna Cai, Hourong Peng, Ting Huyan, Hui Yang · 2021 · International Journal of Medical Sciences
74. Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2
    Jiajing Zheng, Jiameng Miao, Rui Guo, Jinhe Guo, Zheng Fan, Xianbin Kong, Rui Gao, Long Yang · 2022 · Frontiers in Cellular and Infection Microbiology
75. Immune exhaustion in ME/CFS and long COVID
    Natalie Eaton-Fitch, Penny A. Rudd, Teagan Er, Livia C. Hool, Lara J. Herrero, Sonya Marshall‐Gradisnik · 2024 · JCI Insight
76. Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis
    Chao Quan, Caiyan Li, Han Ma, Yisha Li, Huali Zhang · 2020 · Clinical Microbiology Reviews
77. Clinical characteristics and risk factors for mortality among inpatients with COVID‐19 in Wuhan, China
    Fuyang Chen, Wenwu Sun, Shengrong Sun, Zhiyu Li, Zhong Wang, Yu Li · 2020 · Clinical and Translational Medicine
78. Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019
    Leo Francis Buckley, George F. Wohlford, Clara Ting, Abdullah A. Alahmed, Benjamin W. Van Tassell, Antonio Abbate, John W. Devlin, Peter Libby · 2020 · Critical Care Explorations
79. Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact
    Sifan Zhang, Becca Asquith, Richard Szydlo, John S. Tregoning, Katrina M. Pollock · 2021 · Immunotherapy Advances
80. Secondary infections in critically ill patients with COVID-19
    Giacomo Grasselli, Emanuele Cattaneo, Gaetano Florio · 2021 · Critical Care
81. Peripheral blood inflammatory markers in predicting prognosis in patients with COVID‐19. Some differences with influenza A
    Yan Zhao, Chao Yu, Wei Ni, Hua Shen, Mengqi Qiu, Youyun Zhao · 2020 · Journal of Clinical Laboratory Analysis
82. Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019
    Suzane Ramos da Silva, Enguo Ju, Wen Meng, Alberto E. Paniz Mondolfi, Sanja Đačić, Anthony Richard Green, Clare Bryce, Zachary Grimes, Mary Elizabeth Fowkes, Emilia Mia Sordillo et al. · 2021 · The Journal of Infectious Diseases
83. COVID-19 in Immunosuppressed Children
    Emanuele Nicastro, Lucio Verdoni, Laura Rachele Bettini, Giovanna Zuin, Adriana Balduzzi, Giovanni Montini, Andrea Biondi, Lorenzo D’Antiga · 2021 · Frontiers in Pediatrics
84. Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer
    Kathleen Ducoin, Romain Oger, Linda Bilonda Mutala, Cécile Deleine, Nicolas Jouand, Juliette Desfrançois, Juliette Podevin, Emilie Duchalais, Jonathan Cruard, Houssem Benlalam et al. · 2022 · OncoImmunology
85. Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview
    Igor Vladimirovich Kudryavtsev, Artem Rubinstein, А. С. Головкин, Olga Kalinina, Kirill Vasilyev, Руденко Лариса Георгиевна, Исакова-Сивак Ирина Николаевна · 2022 · Viruses
86. Coronavirus disease 2019 (COVID‐19) update: From metabolic reprogramming to immunometabolism
    Mohammad Rudiansyah, Saade Abdalkareem Jasim, Zeinab Gol Mohammad pour, Sara Sohrabi Athar, Ali Salimi Jeda, Rumi Iqbal Doewes, Abduladheem Turki Jalil, Dmitry Olegovich Bokov, Yasser Fakri Mustafa, Mina Noroozbeygi et al. · 2022 · Journal of Medical Virology
87. Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates
    Bert Malengier‐Devlies, Jessica Filtjens, Kourosh Ahmadzadeh, Bram Boeckx, Jessica Vandenhaute, Amber De Visscher, Eline Bernaerts, Tania Mitera, Cato Jacobs, Lore Vanderbeke et al. · 2022 · Frontiers in Immunology
88. Lactiplantibacillus plantarum as a Potential Adjuvant and Delivery System for the Development of SARS-CoV-2 Oral Vaccines
    Julio Villena, Chang Li, María Guadalupe Vizoso-Pinto, Jacinto Sacur, Linzhu Ren, Haruki Kitazawa · 2021 · Microorganisms
89. Immunometabolic signatures predict risk of progression to sepsis in COVID-19
    Ana Sofía Herrera-Van Oostdam, Julio Enrique Castañeda‐Delgado, Juan José Oropeza-Valdez, Juan Carlos Borrego-Moreno, Joel Monárrez‐Espino, Jiamin Zheng, Rupasri Mandal, Lun Zhang, Elizabeth Soto-Guzmán, Julio César Fernández-Ruiz et al. · 2021 · PLoS ONE
90. SARS-CoV-2 ORF8: One protein, seemingly one structure, and many functions
    Smita Vinjamuri, Lenong Li, Marlène Bouvier · 2022 · Frontiers in Immunology
91. Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection
    Tao, Wanyin, Wang, Xiaofang, Zhang, Guorong, Guo, Meng, Ma, Huan, Zhao, Dan, Sun, Yong, He, Jun, Liu, Lianxin, Zhang, Kaiguang et al. · 2021 · Protein & Cell
92. COVID-19 hospitalization rates rise exponentially with age, inversely proportional to thymic T-cell production
    Sam Palmer, Nik J. Cunniffe, Ruairí Donnelly · 2021 · Journal of The Royal Society Interface
93. Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19
    Ali Saeedi‐Boroujeni, Mohammad‐Reza Mahmoudian‐Sani, Roohangiz Nashibi, Sheyda Houshmandfar, Sima Tahmaseby Gandomkari, Ali Khodadadi · 2021 · Immunopharmacology and Immunotoxicology
94. Decreased Serum Selenium Levels of COVID-19 Patients in Comparison with Healthy Individuals
    Ommolbanin Younesian, Behnaz Khodabakhshi, Nafiseh Abdolahi, Alireza Norouzi, Nasser Behnampour, Sara Hosseinzadeh, Seyedeh Somayeh Hosseini Alarzi, Hamidreza Joshaghani · 2021 · Biological Trace Element Research
95. COVID-19: systemic pathology and its implications for therapy
    Qi Shen, Jie Li, Zhan Zhang, Shuang Guo, Qiuhong Wang, Xiaorui An, Haocai Chang · 2021 · International Journal of Biological Sciences
96. COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity
    Kenneth H. Lundstrom, Altijana Hromić‐Jahjefendić, Esma Bilajac, Alaa A. A. Aljabali, Katarina Baralić, Nagwa A. Sabri, Eslam Mansour Shehata, Mohamed Raslan, Ana Cláudia Barbosa Honório Ferreira, Lidiane Orlandi et al. · 2022 · Cellular Signalling
97. COVID-19 : physiopathologie d’une maladie à plusieurs visages
    Vincent Bonny, Alexis Maillard, Cyril Mousseaux, Léo Plaçais, Quentin Richier · 2020 · La Revue de Médecine Interne
98. The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19
    Mahda Delshad, Naeimeh Tavakolinia, Atieh Pourbagheri‐Sigaroodi, Ava Safaroghli‐Azar, Nader Bagheri, Davood Bashash · 2021 · International Immunopharmacology
99. Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs
    Anita Gupta, Gopal S. Gupta · 2021 · Molecular and Cellular Biochemistry
100. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications
     Lijun Chen, Jingjing Qu, Farhin Shaheed Kalyani, Qi Zhang, Lingzhi Fan, Yangxin Fang, Yifei Li, Charlie Xiang · 2022 · Cellular and Molecular Life Sciences